Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 162 clinical trials
HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

Investigators compare in a randomized clinical trial the results and side effects of high-dose- and low-dose-rate brachytherapy as monotherapy in the treatment of early, organ confined

brachytherapy
cancer
prostate specific antigen
  • 18 views
  • 08 Nov, 2020
  • 1 location
Localization of Point A in Cervical Cancer

Point A, the major critical point for dose specification of intracavitary brachytherapy, is defined as the crossing of uterine artery and ureter in treatment of cervical cancer. However

brachytherapy
cancer
  • 4 views
  • 07 Nov, 2020
  • 1 location
No Surgery Trial / Two Dose-escalation Strategies

chemotherapy) and an external beam boost of 9 Gy compared to arm B: standard chemoradiation (45 Gy in 25 with concomitant 5-FU or Xeloda chemotherapy) and followed by a brachytherapy boost of 30 Gy in 3

  • 0 views
  • 12 Mar, 2021
  • 1 location
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

Brachytherapy, or Transperineal implantation of the prostate (TPIP), is a recognized form of treatment for localized cancer of the prostate. TPIP has been used at the British Columbia

rectal ultrasound
brachytherapy
adenocarcinoma of prostate
adenocarcinoma
testosterone
  • 44 views
  • 07 Nov, 2020
  • 1 location
Ultra-hypofractionated Radiation in Prostate Cancer

The primary objective of this study is to demonstrate that ultra-hypofractionation of prostate cancer does not increase urinary toxicity as defined by the EPIC-26 GU domain patient reported outcome.

  • 40 views
  • 25 Jan, 2021
  • 1 location
Trial to Compare Radiation Fibrosis With Five Versus Three Fractions

Post meno-pausal women with T1 Breast cancers will be randomized to receive either 600 centiGray (cGy) X 5 over five consecutive days (arm 1) versus 800 cGy X 3 fractions given every other day (arm 2). Patients will complete treatment in one week. All patients will be followed a month …

  • 0 views
  • 26 Jan, 2021
  • 3 locations
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB Stage II Stage III or Stage IVA Cervical Cancer

RATIONALE: Drugs used in chemotherapy, such as paclitaxel, carboplatin, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving combination chemotherapy together with radiation therapy may …

brachytherapy
paclitaxel
carboplatin
x-rays
tumor cells
  • 41 views
  • 07 Nov, 2020
  • 1 location
A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer

To verify the clinical efficacy and safety of bevacizumab in treating local advanced cervical cancer, present study was designed to investigate the clinical results of bevacizumab combined with concurrent chemoradiotherapy (CCRT) in local advanced cervical cancer

  • 1 views
  • 25 Jan, 2021
  • 1 location
A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer

The aim of this study was to evaluate the progression time and efficacy of brain tumors in patients with brain metastases from HER2-positive breast cancer treated with Pyrrolidine and Capecitabine combined with brain radiotherapy.

  • 0 views
  • 03 Mar, 2021
  • 1 location
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence

Stereo-Re-Pro aims to provide further evidence of Stereotactic Body Radiotherapy (SBRT) as a supplementary non-invasive curative treatment for local recurrence following radiotherapy. The objective of the first part of the trial (Phase I) is to select the recommended dose for salvage SBRT (either 5 x 6 Gy, 6 x 6 …

  • 0 views
  • 25 Jan, 2021
  • 15 locations